Immunomodulating, metabolic and cardioprotective effects of AT1-angiotensin receptors blocker losartan in patients with coronary heart disease and type 2 diabetes mellitus

by A T Teplyakov, S D Mayanskaya, L A Bolotskaya, T V Vdovina, T A Stepacheva, A V Kuznetsova, A V Lukinov, N V Derbeneva, M V Frants, S N Shilov, A T Teplyakov, S D Mayanskaya, L A Bolotskaya, T V Vdovina, T A Stepacheva, A V Kuznetsova, A V Lukinov, N V Derbeneva, M V Frants, S N Shilov
Published 2009-03-01